nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptations and modifications in the technique of laparoscopic hysterectomy with bilateral adnexectomy in the time of COVID-19
|
Saadi, Jose Martin |
|
|
30 |
8 |
p. 1252 |
artikel |
2 |
Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium
|
Nasioudis, Dimitrios |
|
|
30 |
8 |
p. 1089-1094 |
artikel |
3 |
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
|
Ngoi, Natalie YL |
|
|
30 |
8 |
p. 1239-1242 |
artikel |
4 |
A sustainable model for raising colposcopy expertise in low-to-middle-income countries
|
Ismail-Pratt, Ida |
|
|
30 |
8 |
p. 1124-1128 |
artikel |
5 |
Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey
|
Martinelli, Fabio |
|
|
30 |
8 |
p. 1101-1107 |
artikel |
6 |
Comparison of laparoscopic versus open radical hysterectomy in patients with early-stage cervical cancer: a multicenter study in China
|
Hu, Ting wen yi |
|
|
30 |
8 |
p. 1143-1150 |
artikel |
7 |
Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma
|
Pedra Nobre, Silvana |
|
|
30 |
8 |
p. 1162-1168 |
artikel |
8 |
Complication rates and lymph node count between two different skin incisions at time of inguino-femoral lymph node dissection in vulvar cancer
|
Jones, Sadie Esme Fleur |
|
|
30 |
8 |
p. 1113-1117 |
artikel |
9 |
Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
|
|
|
|
30 |
8 |
p. 1266 |
artikel |
10 |
Correction: External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis
|
|
|
|
30 |
8 |
p. 1265 |
artikel |
11 |
Correction: Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
|
|
|
|
30 |
8 |
p. 1267 |
artikel |
12 |
COVID-19: gynecologic cancer surgery at a single center in Madrid
|
de Santiago, Javier |
|
|
30 |
8 |
p. 1108-1112 |
artikel |
13 |
COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby
|
Fujiwara, Keiichi |
|
|
30 |
8 |
p. 1255 |
artikel |
14 |
Creatsas modified vaginoplasty as reconstructive treatment of vaginal stenosis due to vaginal or pelvic radiotherapy
|
Vazquez, Sheila |
|
|
30 |
8 |
p. 1249 |
artikel |
15 |
Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020
|
Madariaga, Ainhoa |
|
|
30 |
8 |
p. 1256-1257 |
artikel |
16 |
European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic
|
Ciavattini, Andrea |
|
|
30 |
8 |
p. 1097-1100 |
artikel |
17 |
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
|
Ngoi, Natalie YL |
|
|
30 |
8 |
p. 1224-1238 |
artikel |
18 |
Getting serious about serous endometrial cancer: should we give chemotherapy in non-invasive cases?
|
Mueller, Jennifer |
|
|
30 |
8 |
p. 1095-1096 |
artikel |
19 |
Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism
|
Filippova, Olga T |
|
|
30 |
8 |
p. 1183-1188 |
artikel |
20 |
HPV vaccination: a Tunisian challenge
|
Ferjaoui, Mohamed Aymen |
|
|
30 |
8 |
p. 1248 |
artikel |
21 |
Intracardiac intravenous leiomyomatosis: diagnosis and management
|
Stilidi, Ivan |
|
|
30 |
8 |
p. 1243-1247 |
artikel |
22 |
Is there a place for lower limb lymphedema prevention after cervical cancer treatment?
|
Baiocchi, Jaqueline Munaretto Timm |
|
|
30 |
8 |
p. 1260 |
artikel |
23 |
Letter to the Editor on Jones SEF, Lim K, Davies J, et al. Complication rates and lymph node count between two different skin incisions at time of inguino-femoral lymph node dissection in vulvar cancer
|
Carvalho, Jesus Paula |
|
|
30 |
8 |
p. 1263 |
artikel |
24 |
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer
|
Contreras, Jessika |
|
|
30 |
8 |
p. 1157-1161 |
artikel |
25 |
Measurement of tumor size in early cervical cancer: an ever-evolving paradigm
|
Salvo, Gloria |
|
|
30 |
8 |
p. 1215-1223 |
artikel |
26 |
Modification of Dargent’s radical vaginal trachelectomy to facilitate ureteral dissection: description of technique
|
Plaikner, Andrea |
|
|
30 |
8 |
p. 1210-1214 |
artikel |
27 |
National trends in bowel and upper abdominal procedures in ovarian cancer surgery
|
Dottino, Joseph A |
|
|
30 |
8 |
p. 1195-1202 |
artikel |
28 |
Ovarian sparing cystectomy for borderline serous tumor through vNOTES (vaginal Natural Orifices Transluminal Endoscopic Surgery)
|
Badiglian-Filho, Levon |
|
|
30 |
8 |
p. 1253-1254 |
artikel |
29 |
Patient-initiated follow-up after treatment for low risk endometrial cancer: a prospective audit of outcomes and cost benefits
|
Coleridge, Sarah |
|
|
30 |
8 |
p. 1177-1182 |
artikel |
30 |
Persistent postoperative ascites successfully identified and treated with laparoscopic indocyanine green fluorescence
|
Fernandes, Rodrigo |
|
|
30 |
8 |
p. 1250-1251 |
artikel |
31 |
Postoperative complications of epidural analgesia at hysterectomy for gynecologic malignancies: an analysis of the National Surgical Quality Improvement Program
|
Ackroyd, Sarah A |
|
|
30 |
8 |
p. 1203-1209 |
artikel |
32 |
Reply to: Is there a place for lower limb lymphedema prevention after cervical cancer treatment?
|
Ding, Yan |
|
|
30 |
8 |
p. 1261-1262 |
artikel |
33 |
Response to a letter from Jesus Paula Carvalho and team regarding the Jones et al article on ‘Complication rates and lymph node count between two different skin incisions at time of inguino-femoral lymph node dissection in vulvar cancer’
|
Jones, Sadie Esme Fleur |
|
|
30 |
8 |
p. 1264 |
artikel |
34 |
Robotic-assisted laparoscopic splenectomy for recurrent ovarian cancer
|
Paterniti, Thomas A |
|
|
30 |
8 |
p. 1189-1194 |
artikel |
35 |
Role of adjuvant therapy in stage IIIC2 endometrial cancer
|
Bogani, Giorgio |
|
|
30 |
8 |
p. 1169-1176 |
artikel |
36 |
Surveillance patterns of cervical cancer patients treated with conization alone
|
Pedra Nobre, Silvana |
|
|
30 |
8 |
p. 1129-1135 |
artikel |
37 |
Tailored radical hysterectomy for locally advanced cervical cancer
|
Sakuragi, Noriaki |
|
|
30 |
8 |
p. 1136-1142 |
artikel |
38 |
Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer
|
Sims, Travis T |
|
|
30 |
8 |
p. 1151-1156 |
artikel |
39 |
Two viral infections in Japan
|
Fujiwara, Keiichi |
|
|
30 |
8 |
p. 1258-1259 |
artikel |
40 |
Vulvar sarcoma outcomes by histologic subtype: a Surveillance, Epidemiology, and End Results (SEER) database review
|
Johnson, Sarah |
|
|
30 |
8 |
p. 1118-1123 |
artikel |